1. Home
  2. PCLA vs ICCC Comparison

PCLA vs ICCC Comparison

Compare PCLA & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PicoCELA Inc. American Depositary Shares

PCLA

PicoCELA Inc. American Depositary Shares

HOLD

Current Price

$6.57

Market Cap

81.6M

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$9.94

Market Cap

93.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCLA
ICCC
Founded
2008
1982
Country
Japan
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.6M
93.1M
IPO Year
2024
1995

Fundamental Metrics

Financial Performance
Metric
PCLA
ICCC
Price
$6.57
$9.94
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 501.6K
11.1K
Earning Date
02-13-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 53.85
EPS
N/A
★ 0.41
Revenue
N/A
★ $26,493,169.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$24.23
Revenue Growth
N/A
★ 51.64
52 Week Low
$0.12
$4.52
52 Week High
$19.61
$12.10

Technical Indicators

Market Signals
Indicator
PCLA
ICCC
Relative Strength Index (RSI) 48.06 47.52
Support Level $6.23 $9.39
Resistance Level $7.50 $10.16
Average True Range (ATR) 1.22 0.29
MACD -0.11 0.03
Stochastic Oscillator 3.50 67.66

Price Performance

Historical Comparison
PCLA
ICCC

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: